Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.
NCT01910038
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Giant Cell Arteritis
Interventions
DRUG:
corticoids+ tocilizumab 8mg/Kg/4 weeks
Sponsor
Centre Hospitalier Universitaire Dijon